Your browser doesn't support javascript.
loading
Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center.
Ak, Naziye; Toker, Alper; Kara, Murat; Özkan, Berker; Ülker, Melike; Kaba, Erkan; Yegen, Gülçin; Karaman, Sule; Dagoglu, Nergiz; Kaytan Saglam, Esra; Oral, Ethem Nezih; Kizir, Ahmet; Bayraktar, Soley; Disçi, Rian; Ferhatoglu, Ferhat; Aydin, Esra; Vatansever, Sezai; Eralp, Yesim; Aydiner, Adnan.
Afiliação
  • Ak N; Department of Medical Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey.
  • Toker A; Department of Thoracic Surgery, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey.
  • Kara M; Department of Thoracic Surgery, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey.
  • Özkan B; Department of Thoracic Surgery, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey.
  • Ülker M; Department of Thoracic Surgery, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey.
  • Kaba E; Department of Thoracic Surgery, Istanbul Florence Nightingale Hospital, Istanbul, Turkey.
  • Yegen G; Department of Pathology, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey.
  • Karaman S; Department of Radiation Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey.
  • Dagoglu N; Department of Radiation Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey.
  • Kaytan Saglam E; Department of Radiation Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey.
  • Oral EN; Department of Radiation Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey.
  • Kizir A; Department of Radiation Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey.
  • Bayraktar S; Department of Medical Oncology, Biruni University School of Medicine, Istanbul, Turkey.
  • Disçi R; Department of Biostatistical Science, Beykent University, Istanbul, Turkey.
  • Ferhatoglu F; Department of Medical Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey.
  • Aydin E; Department of Medical Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey.
  • Vatansever S; Department of Medical Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey.
  • Eralp Y; Department of Medical Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey.
  • Aydiner A; Department of Medical Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey.
Turk Gogus Kalp Damar Cerrahisi Derg ; 29(4): 487-495, 2021 Oct.
Article em En | MEDLINE | ID: mdl-35096446
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article